Troglitazone, a new antidiabetic agent, decreases cyclosporine level.
Park
M H
MH
Pelegrin
D
D
Haug
M T
MT
Young
J B
JB
D000368:Aged; D002839:Chromans / Q000494:pharmacology*; D016572:Cyclosporine / Q000493:pharmacokinetics*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004347:Drug Interactions; D016027:Heart Transplantation; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D013844:Thiazoles / Q000494:pharmacology*; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D016572:Cyclosporine; D000077288:Troglitazone